Active substanceInfliximabInfliximab Similar drugsTo uncover Infliximab lyophilizate d / infusion BIOCAD, CJSC Russia Remicade® lyophilizate d / infusion MSD FARMASYUTIKALS, LLC Russia Flammegis® lyophilizate d / infusion Selltrion Halcocea Co., Ltd. The Republic of Korea Dosage form: & nbsplyophilizate for solution for infusion ATX: & nbspL.04.A.B.02 InfliximabL.04.A.B Inhibitors of tumor necrosis factor-α (TNF-α) Terms of leave from pharmacies:On prescription Registration number:LP-004634 Date of registration:15.01.2018 Expiration Date:15.01.2023 The owner of the registration certificate:BIOCAD, CJSC BIOCAD, CJSC Russia Manufacturer: & nbspBIOCAD, CJSC Russia Illustrated instructions × Illustrated instructions Instructions